Advertisement
Research Article

Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1

  • Tae-Hee Lee,

    Affiliation: Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    ¤ Current address: CHA Stem Cell Institute, College of Medicine, Pochon Cha University, Seoul, Republic of Korea

    X
  • Seyha Seng,

    Affiliation: Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Masayuki Sekine,

    Affiliation: Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Cimona Hinton,

    Affiliation: Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Yigong Fu,

    Affiliation: Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Hava Karsenty Avraham,

    Affiliation: Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Shalom Avraham mail

    To whom correspondence should be addressed. E-mail: savraham@bidmc.harvard.edu

    Affiliation: Division of Experimental Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Published: June 05, 2007
  • DOI: 10.1371/journal.pmed.0040186

Reader Comments (2)

Post a new comment on this article